Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems.[ Read More ]
The intrinsic value of one BDX stock under the base case scenario is HIDDEN Compared to the current market price of 225 USD, Becton, Dickinson and Company is HIDDEN
Current Assets | 8.68 B |
Cash & Short-Term Investments | 1.42 B |
Receivables | 2.53 B |
Other Current Assets | 4.72 B |
Non-Current Assets | 44.1 B |
Long-Term Investments | 0 |
PP&E | 7.07 B |
Other Non-Current Assets | 37 B |
Current Liabilities | 6.64 B |
Accounts Payable | 1.64 B |
Short-Term Debt | 1.14 B |
Other Current Liabilities | 3.86 B |
Non-Current Liabilities | 20.3 B |
Long-Term Debt | 15.2 B |
Other Non-Current Liabilities | 5.19 B |
Revenue | 20.2 B |
Cost Of Revenue | 0 |
Gross Profit | 20.2 B |
Operating Expenses | 6.05 B |
Operating Income | 2.42 B |
Other Expenses | 699 M |
Net Income | 1.73 B |
Net Income | 1.73 B |
Depreciation & Amortization | 2.29 B |
Capital Expenditures | -725 M |
Stock-Based Compensation | 0 |
Change in Working Capital | 0 |
Others | -168 M |
Free Cash Flow | 3.12 B |
Date | Value | Insider | Amount | Avg Price |
---|---|---|---|---|
5 months ago
Jun 10, 2024
|
Sell 71.8 K USD
|
Spoerel Thomas J
SVP,Controller&Chief Acct Off |
- 300
|
239.31 USD |
6 months ago
May 15, 2024
|
Sell 188 K USD
|
Goette Roland
EVP and President EMEA |
- 800
|
235.29 USD |
6 months ago
May 15, 2024
|
Sell 332 K USD
|
Goette Roland
EVP and President EMEA |
- 1400
|
236.99 USD |
6 months ago
May 15, 2024
|
Sell 261 K USD
|
Goette Roland
EVP and President EMEA |
- 1100
|
237.46 USD |
6 months ago
May 13, 2024
|
Sell 402 K USD
|
Goette Roland
EVP and President EMEA |
- 1700
|
236.28 USD |
6 months ago
May 13, 2024
|
Sell 373 K USD
|
Goette Roland
EVP and President EMEA |
- 1572
|
237.14 USD |
6 months ago
May 13, 2024
|
Sell 6.66 K USD
|
Goette Roland
EVP and President EMEA |
- 28
|
237.9 USD |
6 months ago
Apr 30, 2024
|
Sell 399 K USD
|
Garrison Michael David
EVP & President Medical |
- 1715
|
232.81 USD |
8 months ago
Mar 14, 2024
|
Sell 67.2 K USD
|
Spoerel Thomas J
SVP,Controller&Chief Acct Off |
- 282
|
238.29 USD |
11 months ago
Dec 11, 2023
|
Sell 288 K USD
|
Garrison Michael David
EVP & President Medical |
- 1239
|
232.46 USD |
11 months ago
Nov 28, 2023
|
Sell 514 K USD
|
Byrd Richard
EVP & President Interventional |
- 2156
|
238.47 USD |
1 year ago
Sep 05, 2023
|
Sell 126 K USD
|
Byrd Richard
EVP & President Interventional |
- 459
|
274.48 USD |
1 year ago
Aug 28, 2023
|
Sell 239 K USD
|
Fraser Claire
Director |
- 848
|
281.66 USD |
1 year ago
Aug 11, 2023
|
Sell 826 K USD
|
Hickey David
EVP & President, Life Sciences |
- 2974
|
277.85 USD |
1 year ago
Aug 08, 2023
|
Sell 360 K USD
|
Garrison Michael David
EVP & President Medical |
- 1300
|
277.13 USD |
1 year ago
Feb 03, 2023
|
Sell 353 K USD
|
Byrd Richard
EVP & President Interventional |
- 1421
|
248.6 USD |
2 years ago
Aug 15, 2022
|
Sell 126 K USD
|
Hickey David
EVP & President, Life Sciences |
- 475
|
265 USD |
2 years ago
Aug 15, 2022
|
Sell 2.52 M USD
|
Polen Thomas E Jr
Chairman, CEO and President |
- 9500
|
265.13 USD |
2 years ago
Aug 09, 2022
|
Sell 1.9 M USD
|
Khichi Samrat S.
EVP and General Counsel |
- 7295
|
260.44 USD |
2 years ago
Aug 09, 2022
|
Sell 430 K USD
|
Polen Thomas E Jr
Executive Vice President |
- 1652
|
260 USD |
2 years ago
Jun 07, 2022
|
Sell 115 K USD
|
Spoerel Thomas J
VP Controller & Chief Acct Off |
- 443
|
260 USD |
2 years ago
May 06, 2022
|
Sell 122 K USD
|
Hickey David
EVP & President, Life Sciences |
- 475
|
256 USD |
2 years ago
Feb 25, 2022
|
Sell 163 K USD
|
Larson Betty D
EVP HR & CHRO |
- 601
|
271.9 USD |
2 years ago
Feb 08, 2022
|
Sell 228 K USD
|
Fraser Claire
Director |
- 841
|
271.7 USD |
2 years ago
Feb 03, 2022
|
Sell 1.73 M USD
|
Conroy Alexandre
EVP of Integrated Supply Chain |
- 6410
|
270.16 USD |
2 years ago
Dec 16, 2021
|
Sell 141 K USD
|
Larson Betty D
EVP HR & CHRO |
- 552
|
255 USD |
2 years ago
Dec 16, 2021
|
Sell 711 K USD
|
Larson Betty D
EVP HR & CHRO |
- 2789
|
255 USD |
2 years ago
Dec 07, 2021
|
Sell 58.2 K USD
|
Spoerel Thomas J
VP Controller & Chief Acct Off |
- 233
|
250 USD |
3 years ago
Sep 08, 2021
|
Sell 69.4 K USD
|
Spoerel Thomas J
VP Controller & Chief Acct Off |
- 267
|
260 USD |
3 years ago
Sep 08, 2021
|
Sell 130 K USD
|
Hickey David
EVP & President, Life Sciences |
- 500
|
260 USD |
3 years ago
Sep 08, 2021
|
Sell 130 K USD
|
RIMEL REBECCA W
Director |
- 500
|
260 USD |
3 years ago
Sep 03, 2021
|
Sell 1.79 M USD
|
Lim James C
Executive Vice President |
- 6956
|
257.44 USD |
3 years ago
Sep 03, 2021
|
Sell 129 K USD
|
RIMEL REBECCA W
Director |
- 500
|
257.1 USD |
3 years ago
Sep 02, 2021
|
Sell 62 K USD
|
RIMEL REBECCA W
Director |
- 244
|
254 USD |
3 years ago
Aug 30, 2021
|
Sell 52.2 K USD
|
RIMEL REBECCA W
Director |
- 207
|
252 USD |
3 years ago
Aug 18, 2021
|
Sell 97.4 K USD
|
Fraser Claire
Director |
- 387
|
251.58 USD |
3 years ago
Aug 17, 2021
|
Sell 52.2 K USD
|
RIMEL REBECCA W
Director |
- 207
|
252 USD |
3 years ago
Aug 06, 2021
|
Sell 64.5 K USD
|
Spoerel Thomas J
VP Controller & Chief Acct Off |
- 266
|
242.3 USD |
3 years ago
May 28, 2021
|
Sell 829 K USD
|
Lim James C
Executive Vice President |
- 3429
|
241.68 USD |
3 years ago
May 27, 2021
|
Sell 94.1 K USD
|
Fraser Claire
Director |
- 390
|
241.36 USD |
3 years ago
Nov 23, 2020
|
Sell 214 K USD
|
Goette Roland
EVP and President, EMEA |
- 930
|
230.1 USD |
4 years ago
Jul 09, 2020
|
Sell 331 K USD
|
Kaltenbach Patrick
EVP & Pres Life Sciences |
- 1272
|
260 USD |
4 years ago
Jun 05, 2020
|
Sell 255 K USD
|
Kaltenbach Patrick
EVP & Pres Life Sciences |
- 1049
|
243.2 USD |
4 years ago
Jun 02, 2020
|
Sell 54.4 K USD
|
Kaltenbach Patrick
EVP & Pres Life Sciences |
- 222
|
244.83 USD |
4 years ago
May 08, 2020
|
Sell 198 K USD
|
Fraser Claire
Director |
- 771
|
256.56 USD |
4 years ago
Mar 16, 2020
|
Sell 976 K USD
|
Khichi Samrat S.
EVP and General Counsel |
- 4349
|
224.53 USD |
4 years ago
Feb 11, 2020
|
Sell 207 K USD
|
Fraser Claire
Director |
- 800
|
258.73 USD |
4 years ago
Feb 11, 2020
|
Sell 181 K USD
|
Fraser Claire
Director |
- 700
|
258.7 USD |
4 years ago
Feb 04, 2020
|
Sell 410 K USD
|
Campion Simon D
EVP and Segment President |
- 1439
|
285.09 USD |
4 years ago
Feb 04, 2020
|
Sell 408 K USD
|
Mas Ribo Alberto
EVP and Pres, Life Sciences |
- 1430
|
285 USD |
4 years ago
Jan 28, 2020
|
Sell 8.01 M USD
|
FORLENZA VINCENT A
Chairman, CEO and President |
- 28514
|
280.96 USD |
4 years ago
Jan 27, 2020
|
Sell 7.16 M USD
|
FORLENZA VINCENT A
Chairman, CEO and President |
- 25546
|
280.09 USD |
4 years ago
Jan 23, 2020
|
Sell 1.76 M USD
|
FORLENZA VINCENT A
Chairman, CEO and President |
- 6284
|
280.06 USD |
4 years ago
Jan 24, 2020
|
Sell 2.01 M USD
|
FORLENZA VINCENT A
Chairman, CEO and President |
- 7177
|
280.13 USD |
4 years ago
Jan 08, 2020
|
Sell 3.81 M USD
|
FORLENZA VINCENT A
Chairman, CEO and President |
- 13860
|
275.19 USD |
4 years ago
Jan 10, 2020
|
Sell 5.41 M USD
|
FORLENZA VINCENT A
Chairman, CEO and President |
- 19675
|
275.15 USD |
4 years ago
Jan 02, 2020
|
Sell 9.05 M USD
|
FORLENZA VINCENT A
Chairman, CEO and President |
- 33365
|
271.28 USD |
4 years ago
Dec 16, 2019
|
Sell 3.2 M USD
|
Mas Ribo Alberto
EVP and Pres, Life Sciences |
- 11860
|
269.51 USD |
4 years ago
Dec 16, 2019
|
Sell 1.2 M USD
|
Polen Thomas E Jr
Executive Vice President |
- 4432
|
269.63 USD |
4 years ago
Dec 12, 2019
|
Sell 89.2 K USD
|
Kaltenbach Patrick
EVP & Pres Life Sciences |
- 339
|
263.23 USD |
4 years ago
Dec 12, 2019
|
Sell 3.09 M USD
|
FORLENZA VINCENT A
Chairman, CEO and President |
- 11626
|
265.57 USD |
4 years ago
Dec 13, 2019
|
Sell 136 K USD
|
Spoerel Thomas J
VP Controller & Chief Acct Off |
- 506
|
267.95 USD |
4 years ago
Dec 06, 2019
|
Sell 81.6 K USD
|
Kaltenbach Patrick
EVP & Pres Life Sciences |
- 312
|
261.51 USD |